We focus on the research and development of biopharmaceuticals for Type 2 diabetes.

We aim to grow into a global leader in the sector of biopharmaceutical technologies.

Our offering for Type 2 diabetes is E2HSA
Recombinant exenatide-human serum albumin. Learn More


E2HSA will facilitate major changes in the treatment of diabetes and bring hope to tens of thousands of diabetics.
Explore more